WallStreetZenWallStreetZen

NYSE: ENZ
Enzo Biochem Revenue

OverviewEarningsRevenue
DividendOwnership
Enzo Biochem revenue was $29.10M for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Jan 31, 2025 was $7.3M, up 18% from last quarter. For the last reported fiscal year 2024 ending Jul 31, 2024, ENZ annual revenue was $31.9M, with 2.7% growth year-over-year.

ENZ past revenue growth

How has ENZ's revenue growth performed historically?

Company
-11.3%
Industry
3.9%
Market
20.87%
ENZ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ENZ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ENZ's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ENZ revenue history

Current Revenue
$29.1M
Current Earnings
-$21.3M
Current Profit Margin
-73.2%

Be the first to know when ENZ announces revenue.

ENZ Revenue History By Year

ENZ Yearly RevenueENZ RevenueENZ ChangeENZ Revenue Growth
2024-07-31$31.91M$846.00k+2.72%
2023-07-31$31.06M-$1.58M-4.85%
2022-07-31$32.64M-$85.09M-72.27%
2021-07-31$117.73M$41.71M+54.87%
2020-07-31$76.02M-$5.15M-6.34%
2019-07-31$81.17M-$19.84M-19.64%
2018-07-31$101.01M-$4.07M-3.88%
2017-07-31$105.09M$2.31M+2.25%
2016-07-31$102.77M$5.17M+5.30%
2015-07-31$97.60M$1.65M+1.72%
2014-07-31$95.95M$2.24M+2.39%
2013-07-31$93.71M-$9.38M-9.10%
2012-07-31$103.08M$1.05M+1.03%
2011-07-31$102.03M$4.95M+5.10%
2010-07-31$97.08M$7.51M+8.38%
2009-07-31$89.57M$11.78M+15.14%
2008-07-31$77.80M$24.89M+47.04%
2007-07-31$52.91M$13.08M+32.85%
2006-07-31$39.83M-$3.58M-8.24%
2005-07-31$43.40M$1.76M+4.22%
2004-07-31$41.64M-$11.12M-21.08%
2003-07-31$52.77M-$1.25M-2.31%
2002-07-31$54.02M$1.75M+3.35%
2001-07-31$52.27M$9.42M+21.98%
2000-07-31$42.85M-$1.47M-3.32%
1999-07-31$44.32M$3.90M+9.66%
1998-07-31$40.42M$5.48M+15.68%
1997-07-31$34.94M$448.20k+1.30%
1996-07-31$34.49M$2.79M+8.80%
1995-07-31$31.70M$9.90M+45.43%
1994-07-31$21.80MN/AN/A

1 of 3

Enzo Biochem Revenue FAQ

What was ENZ's revenue last quarter?

On Invalid Date, Enzo Biochem (NYSE: ENZ) reported Q4 2024 revenue of $7.33 million up 14.25% year over year. In the same quarter last year, Enzo Biochem's revenue was $8.55 million.

What was Enzo Biochem's revenue in 2024?

Enzo Biochem's annual revenue for the twelve months ending Jul 31, 2024 was $31.91 million, a 2.72% increase year over year.

How much does Enzo Biochem make in a day?

Based on Enzo Biochem annual revenue for the past five years, ENZ makes an average of $158,555.07 per day.

What was Enzo Biochem's annual revenue growth in the past year?

As of Q2 2025, Enzo Biochem's revenue has grown -11.3% year over year. This is 15.21 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 3.9%. Enzo Biochem's revenue in the past year totaled $29.10 million.

How much does Enzo Biochem make in a year?

Enzo Biochem's revenue by year for the past five years is:
  • Enzo Biochem's revenue for the twelve months ending Jul 31, 2024 was $31.91 million, a 2.72% increase year over year.
  • Enzo Biochem's annual revenue for Jul 31, 2023 was $31.06 million, a 4.85% decrease from 2022.
  • Enzo Biochem's annual revenue for 2022 was $32.64 million, a 72.27% decrease from 2021.
  • Enzo Biochem's annual revenue for 2021 was $117.73 million, a 54.87% increase from 2020.
  • Enzo Biochem's annual revenue for 2020 was $76.02 million, a 6.34% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.